Feminizing adrenal tumor identified by plasma steroid profiling
Vogt, Elinor Margrethe Chelsom; Hammerling, Katrin; Sorbye, Halfdan; Heie, Anette; Sulen, André; Ueland, Grethe Åstrøm; Husebye, Eystein Sverre; Methlie, Paal
Journal article, Peer reviewed
Published version
![Thumbnail](/bora-xmlui/bitstream/handle/11250/2987062/%255B20520573%2b-%2bEndocrinology%252C%2bDiabetes%2b%2526%2bMetabolism%2bCase%2bReports%255D%2bFeminizing%2badrenal%2btumor%2bidentified%2bby%2bplasma%2bsteroid%2bprofiling.pdf.jpg?sequence=6&isAllowed=y)
Åpne
Permanent lenke
https://hdl.handle.net/11250/2987062Utgivelsesdato
2021Metadata
Vis full innførselSamlinger
- Department of Clinical Science [2379]
- Registrations from Cristin [10237]
Originalversjon
Endocrinology, Diabetes and Metabolism Case Reports. 2021, 2021 (1), 21-0104. 10.1530/EDM-21-0104Sammendrag
Feminizing estrogen-secreting adrenocortical carcinomas (ACCs) are exceedingly rare and carry a poor prognosis. The most common presenting trait is gynecomastia, but enlarged breasts are also a frequent clinical finding in healthy men. Biochemical evaluation may be challenging. As such, there is a high risk of delayed diagnosis and treatment opportunity. Here, we present a case with an estrogen-producing ACC where the abnormal steroid profile obtained at the time of initial workup was essential for the prompt diagnosis. Wider adoption of liquid chromatography mass spectrometry-based steroid assays has potential to improve early diagnosis of feminizing estrogen-secreting ACC.